ImmuCell
ICCC
ICCC
19 hedge funds and large institutions have $5.31M invested in ImmuCell in 2018 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Holders
19
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$43.3K | |
| 2 | +$23K | |
| 3 | +$7.07K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.82K |
Top Sellers
| 1 | -$87K | |
| 2 | -$37K | |
| 3 | -$30.3K | |
| 4 |
EFS
Essex Financial Services
Essex,
Connecticut
|
-$19.6K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.75K |